Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harte-Hanks

4.12
-0.2200-5.07%
Post-market: 4.120.00000.00%16:04 EDT
Volume:36.07K
Turnover:149.61K
Market Cap:30.34M
PE:-0.99
High:4.40
Open:4.15
Low:3.94
Close:4.34
Loading ...
OverviewCompanyNewsFilings

TOMI Environmental Solutions Positioned to Address Growing Global Disease Threats with SteraMist Technology

GlobeNewswire
·
10 Jan

Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

Dow Jones
·
08 Jan

Press Release: Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dow Jones
·
08 Jan

Basilea provides portfolio update and outlook

GlobeNewswire
·
08 Jan

ASX December health sector winners… and a 91pc drop for a trial-flopped stock

Stockheads
·
08 Jan

Surgeon General Wants Alcohol Warning Labels to Note Cancer Risk

Investopedia
·
04 Jan

ASX healthcare 2024 winners and losers, plus what’s next for 2025

Stockheads
·
31 Dec 2024

The US proposes rules to make healthcare data more secure

The Verge
·
28 Dec 2024

Eli Lilly, Amgen Sue HHS for Unlawful Certifications of Drug Discount Program Recipients

MT Newswires Live
·
24 Dec 2024

Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients

MT Newswires Live
·
24 Dec 2024

Press Release: Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera(R) (ceftobiprole) in the United States

Dow Jones
·
16 Dec 2024

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
May 14, 2025 Post Market
Financial Report Announcement
Mar 17, 2025 Post Market
Financial Report Announcement
Nov 14, 2024 Post Market
Financial Report Announcement
May 09, 2024 Post Market
Financial Report Announcement
Mar 14, 2024 Post Market

Dividend History

Ex-DateDividend
2015-08-280.085
2015-11-270.085
2016-02-260.085

Valuation Analysis

-1.06
Current
-2.86
Sector Average
48.54%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.06
Maximum
8.69
+1 STD
10.63
Minimum
-67.00
-1 STD
-16.36
Average
-2.86

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.